{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T15:07:53Z","timestamp":1780758473231,"version":"3.54.1"},"reference-count":16,"publisher":"Pharmaceutical Society of Japan","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2020,5,1]]},"DOI":"10.1248\/bpb.b19-01116","type":"journal-article","created":{"date-parts":[[2020,3,3]],"date-time":"2020-03-03T22:03:33Z","timestamp":1583273013000},"page":"913-916","source":"Crossref","is-referenced-by-count":4,"title":["Frequency of Clinical Monitoring of Serum Concentrations of Digoxin, Potassium, and Creatinine, and Recording of Electrocardiograms in Digoxin-Treated Patients: A Japanese Claims Database Analysis"],"prefix":"10.1248","volume":"43","author":[{"given":"Nobuhiro","family":"Ooba","sequence":"first","affiliation":[{"name":"Nihon University School of Pharmacy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayaka","family":"Sente","sequence":"additional","affiliation":[{"name":"Nihon University School of Pharmacy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megumi","family":"Abe","sequence":"additional","affiliation":[{"name":"Nihon University School of Pharmacy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumiyuki","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Nihon University School of Pharmacy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Tsutsumi","sequence":"additional","affiliation":[{"name":"Nihon University School of Pharmacy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiminobu","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Nihon University School of Pharmacy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshimitsu","family":"Nakayama","sequence":"additional","affiliation":[{"name":"Nihon University School of Pharmacy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Kimura","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Tokyo University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriyasu","family":"Fukuoka","sequence":"additional","affiliation":[{"name":"Nihon University School of Pharmacy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"163","reference":[{"key":"1","unstructured":"1) van Veldhuisen DJ, Van Gelder IC, Ahmed A, Gheorghiade M. Digoxin for patients with atrial fibrillation and heart failure: paradise lost or not? <i>Eur. Heart J.<\/i>, <b>34<\/b>, 1468\u20131470 (2013)."},{"key":"2","unstructured":"2) Ziff OJ, Lane DA, Samra M, Griffith M, Kirchhof P, Lip GY, Steeds RP, Townend J, Kotecha D. Safety and efficacy of digoxin: systematic review and meta-analysis of observational and controlled trial data. <i>BMJ<\/i>, <b>351<\/b>, h4451 (2015)."},{"key":"3","unstructured":"3) Yancy CW, Jessup M, Bozkurt B, <i>et al.<\/i> 2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. <i>J. Am. Coll. Cardiol.<\/i>, <b>62<\/b>, e147\u2013e239 (2013)."},{"key":"4","unstructured":"4) Brieger D, Amerena J, Attia J, Bajorek B, Chan KH, Connell C, Freedman B, Ferguson C, Hall T, Haqqani H, Hendriks J, Hespe C, Hung J, Kalman JM, Sanders P, Worthington J, Yan TD, Zwar N. National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand: Australian clinical guidelines for the diagnosis and management of atrial fibrillation 2018. <i>Heart Lung Circ.<\/i>, <b>27<\/b>, 1209\u20131266 (2018)."},{"key":"5","unstructured":"5) See I, Shehab N, Kegler SR, Laskar SR, Budnitz DS. Emergency department visits and hospitalizations for digoxin toxicity: United States, 2005 to 2010. <i>Circ Heart Fail<\/i>, <b>7<\/b>, 28\u201334 (2014)."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Shehab N, Lovegrove MC, Geller AI, Rose KO, Weidle NJ, Budnitz DS. US Emergency Department visits for outpatient adverse drug events, 2013\u20132014. <i>JAMA<\/i>, <b>316<\/b>, 2115\u20132125 (2016).","DOI":"10.1001\/jama.2016.16201"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Raebel MA, Carroll NM, Andrade SE, Chester EA, Lafata JE, Feldstein A, Gunter MJ, Nelson WW, Simon SR, Chan KA, Davis RL, Platt R. Monitoring of drugs with a narrow therapeutic range in ambulatory care. <i>Am. J. Manag. Care<\/i>, <b>12<\/b>, 268\u2013274 (2006).","DOI":"10.18553\/jmcp.2006.12.8.656"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Rathore SS, Curtis JP, Wang Y, Bristow MR, Krumholz HM. Association of serum digoxin concentration and outcomes in patients with heart failure. <i>JAMA<\/i>, <b>289<\/b>, 871\u2013878 (2003).","DOI":"10.1001\/jama.289.7.871"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Shapiro W, Taubert K, Narahara K. Nonradioactive serum digoxin and digitoxin levels. <i>Arch. Intern. Med.<\/i>, <b>130<\/b>, 31\u201336 (1972).","DOI":"10.1001\/archinte.130.1.31"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Aonuma K, Shiga T, Atarashi H, <i>et al.<\/i> Guidelines for therapeutic drug monitoring of cardiovascular drugs clinical use of blood drug concentration monitoring (JCS 2015)-digest version. <i>Circ. J.<\/i>, <b>81<\/b>, 581\u2013612 (2017).","DOI":"10.1253\/circj.CJ-66-0138"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Takada M, Goto T, Kotake T, Saito M, Kawato N, Nakai M, Gunji T, Shibakawa M. Appropriate dosing of antiarrhythmic drugs in Japan requires therapeutic drug monitoring. <i>J. Clin. Pharm. Ther.<\/i>, <b>30<\/b>, 5\u201312 (2005).","DOI":"10.1111\/j.1365-2710.2004.00612.x"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Tjia J, Fischer SH, Raebel MA, Peterson D, Zhao Y, Gagne SJ, Gurwitz JH, Field TS. Baseline and follow-up laboratory monitoring of cardiovascular medications. <i>Ann. Pharmacother.<\/i>, <b>45<\/b>, 1077\u20131084 (2011).","DOI":"10.1345\/aph.1Q158"},{"key":"13","unstructured":"13) Kimura S, Sato T, Ikeda S, Noda M, Nakayama T. Development of a database of health insurance claims: standardization of disease classifications and anonymous record linkage. <i>J. Epidemiol.<\/i>, <b>20<\/b>, 413\u2013419 (2010)."},{"key":"14","unstructured":"14) Ooba N, Tsutsumi D, Kobayashi N, Hidaka S, Hayashi H, Obara T, Satoh M, Kubota K, Fukuoka N. Prevalence of therapeutic drug monitoring for lithium and the impact of regulatory warnings: analysis using Japanese claims database. <i>Ther. Drug Monit.<\/i>, <b>40<\/b>, 252\u2013256 (2018)."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Raebel MA, Lyons EE, Andrade SE, Chan KA, Chester EA, Davis RL, Ellis JL, Feldstein A, Gunter MJ, Lafata JE, Long CL, Magid DJ, Selby JV, Simon SR, Platt R. Laboratory monitoring of drugs at initiation of therapy in ambulatory care. <i>J. Gen. Intern. Med.<\/i>, <b>20<\/b>, 1120\u20131126 (2005).","DOI":"10.1111\/j.1525-1497.2005.0257.x"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Maciejewski ML, Mi X, Curtis LH, Ng J, Haffer SC, Hammill BG. Few disparities in baseline laboratory testing after the diuretic or digoxin initiation by medicare fee-for-service beneficiaries. <i>Circ. Cardiovasc. Qual. Outcomes<\/i>, <b>9<\/b>, 714\u2013722 (2016).","DOI":"10.1161\/CIRCOUTCOMES.116.003052"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/43\/5\/43_b19-01116\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T06:32:47Z","timestamp":1588833167000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/43\/5\/43_b19-01116\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,1]]},"references-count":16,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b19-01116","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,1]]}}}